Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2K Buy
+500
New +$1.06K ﹤0.01% 1863
2022
Q2
Sell
-768
Closed -$5.29K 5389
2022
Q1
$6K Sell
768
-264
-26% -$2.25K ﹤0.01% 4019
2021
Q4
$9K Sell
1,032
-28
-3% -$325 ﹤0.01% 3795
2021
Q3
$12K Sell
1,060
-350
-25% -$4.86K ﹤0.01% 3775
2021
Q2
$21K Buy
1,410
+1,010
+253% +$15.9K ﹤0.01% 3270
2021
Q1
$6K Sell
400
-1,550
-79% -$29.3K ﹤0.01% 4251
2020
Q4
$33K Sell
1,950
-400
-17% -$9.85K ﹤0.01% 2301
2020
Q3
$87K Buy
2,350
+1,350
+135% +$42.3K 0.01% 1414
2020
Q2
$22K Sell
1,000
-650
-39% -$13.9K ﹤0.01% 2317
2020
Q1
$14K Buy
+1,650
New +$25.3K ﹤0.01% 2531

Other funds holding MESO

Cutler Group's MESO Position: Q1 2024 in Review

Cutler Group opened a new position in Mesoblast (MESO) in Q1 2024: 500 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1863 among its holdings. This is a return to the name: Cutler Group previously reported a position in MESO as recently as Q1 2022.

Cutler Group first reported a position in MESO in Q1 2020 and has held it in 10 quarters since. The position peaked at $87K in Q3 2020. 26 funds tracked by Wall St. Rank hold MESO as of Q1 2024.

  • Cutler Group held 500 shares of Mesoblast worth $2K as of Q1 2024.
  • Mesoblast was a new Cutler Group position in Q1 2024.
  • Mesoblast made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1863 holding.
  • Cutler Group first reported a position in Mesoblast in Q1 2020 and has held it in 10 quarters since.
  • Cutler Group's Mesoblast position peaked at $87K in Q3 2020.
  • 26 funds tracked by Wall St. Rank held Mesoblast as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.